Seeking Alpha

More on Allscripts (MDRX): Q4 misses on all counts as results were hit by weaker sales, a...

More on Allscripts (MDRX): Q4 misses on all counts as results were hit by weaker sales, a deferred-revenue provision plus other items. Total revenue declined 9.6% Y/Y and gross margin fell to 38.8% from 45.1%. One bright spot however, was bookings - a key leading indicator for health IT firms - which came in at $180.7M, well ahead of consensus expectations. That is driving the stock higher in the post-trading session, with shares currently +6.4%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector